FindMyKOL
Clinical trialNCT07101666Not, yet, recruitingPhase 2Interventional

Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer

SponsorWashington University School of MedicineEnrollment20Gastric Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Standard treatment for patients with early stage gastric cancer consists of perioperative chemotherapy and surgical resection. If radiation therapy is administered in the adjuvant setting, the radiated area is often large and associated with significant toxicity. In this study, the investigators propose the addition of short course radiation therapy (SCRT) to chemotherapy in the neoadjuvant setting. The investigators hypothesize that this regimen of Total Neoadjuvant Therapy (TNT) will result in a higher rate of complete response (both pathologic and clinical), with less toxicity.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Patrick Grierson, M.D., Ph.D.

    Washington University School of Medicine

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucla

    Los Angeles, California, United States

    Ann Raldow, M.D.
  • Moffitt Cancer Center

    Tampa, Florida, United States

    Jessica Frakes, M.D.
  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

    Haeseong Park, M.D.
  • Washington University School of Medicine

    St Louis, Missouri, United States

    Benjamin Tan, M.D.Carl DeSelm, M.D., Ph.D.David DeNardo, Ph.D.Dominic Sanford, M.D.Esther Lu, Ph.D.Hyun Kim, M.D.Kian-Huat Lim, M.D., Ph.D.Michael Waters, M.D., Ph.D.Natasha Leigh-Matijakovich, M.D.Patrick Grierson, M.D., Ph.D.Rama Suresh, M.D.Roheena Panni, M.D., Ph.D.Shawn Wu, Ph.D.

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Standard of care neoadjuvant chemotherapy
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2026
Primary completion
30 Apr 2031
Completion
30 Apr 2031
Last update posted
6 Aug 2026
Registered enrollment
20
Registry id
NCT07101666

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.